Author

Lori Smith

Observed name: L Mary Smith

OpenAlex ID: A5034623041

Taxanes can enhance immunotherapy of cancer - importance of timing

2008 · Birgit C. Schultes, Fuxiang Hou, et al. · Cancer Research · 1

How Various Breast Cancer Screening Guidelines Compare

2019 · Lori Smith, Crnp

10 Recent Oncology Drug Approvals

2019 · Lori Smith, Crnp

Does Diet Matter for Breast Cancer Survivors

2018 · Lori Smith, Crnp

How Can We Improve Stress Levels in Cancer Patients

2018 · Lori Smith, Crnp

Nurse-Led Smoking-Cessation Program for Cancer Patients Doubled the Quit Rate

2018 · Lori Smith, Crnp

New Findings for Women With Chemo-Resistant Ovarian, Peritoneal Cancer

2017 · Lori Smith, Crnp

Accelerated Approval of Rucaparib to Treat Ovarian Cancer

2017 · Lori Smith, Crnp

Bevacizumab Plus Chemotherapy Receives FDA Approval for Ovarian Cancer

2016 · Lori Smith, Crnp

The Role of the Microbiome in Treating Women With Recurrent Ovarian Cancer

2016 · Lori Smith, Crnp

Ovarian Cancer Risk May Increase in Women With Irregular Menses

2016 · Lori Smith, Crnp

Study Finds Knowledge Gaps in Ovarian Cancer

2016 · Lori Smith, Crnp

Immunization with PSA/anti-PSA complexes induces T and B cell responses to PSA in PSA-transgenic mice (48.19)

2007 · Birgit Corinna Schultes, Fuxiang Hou, et al. · The Journal of Immunology

Front-Line Chemo-Immunotherapy With Carboplatin-Paclitaxel and Oregovomab in Stage III/IV Ovarian Cancer

2005 · L Mary Smith, Birgit Schultes, et al. · Journal of Immunotherapy

Works count: 14

Citation count: 1

H-index: 1

I10-index: